Placental expression of nitric oxide synthase during HELLP syndrome: The correlation with maternal-fetal Doppler velocimetry

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 9, 2005, Pages 849-853

  Tranquilli, Andrea L ^a   Giannubilo, Stefano R ^a   Tedeschi, Elisa ^b   Bezzeccheri, Valeria ^a   Suzuki, Hisanori ^b   Menegazzi, Marta ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Doppler; HELLP; Nitric oxide; Pregnancy

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER FLOWMETER; FEMALE; HELLP SYNDROME; HUMAN; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSE WAVE; UMBILICAL ARTERY; UTERINE ARTERY; WAVEFORM;

ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; FEMALE; HELLP SYNDROME; HUMANS; NITRIC OXIDE SYNTHASE; PLACENTA; PREGNANCY; PULSATILE FLOW; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UMBILICAL ARTERIES; UTERUS;

EID: 24044488930     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00756.x     Document Type: Article

References (24)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-67.
2. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1986; 155: 501-9.
3. Parra MC, Lees C, Mann GE, Pearson JD, Nicolaides KH. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia. Am J Obstet Gynecol 2001; 184: 497-502.
4. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
5. Lowenstein CJ, Dinnerman JL, Snyder H. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120: 227-37.
6. Baylis C, Suto T, Conrad K. Importance of nitric oxide in control of systemic and renal hemodynamics during normal pregnancy: studies in the rat and implications for preeclampsia. Hypertens Pregnancy 1996; 15: 147-69.
7. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272: 441-63.
8. Chang JK, Roman C, Heymann MA. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero. Am J Obstet Gynecol 1992; 166: 727-34.
9. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501-9.
10. American College of Obstetricians and Gynecologists. Intrauterine growth restriction. In: ACOG practice bulletin no. 12. Washington, DC: American College of Obstetricians and Gynecologists, 2000.
11. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-9.
12. Gosling RG, King DH. Ultrasound angiology. In: Marcus AW, Adamson L (eds): Arteries and veins. Edinburgh: Churchill Livingstone, 1975: 61-98.
13. Higgins JR, Brennecke SP. Pre-eclampsia-still a disease of theories? Curr Opin Obstet Gynecol 1998; 10: 129-33.
14. Roberts JM, Taylor RN, Musci TJ, Rogers GM, Hubel CA, McLaughlin MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-4.
15. King RG, Gude NM, Di Iulio JL, Brennecke SP. Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev 1995; 7: 1407-11.
16. Morris NH, Sooranna SR, Learmont JG et al. Nitric oxide synthase activities in placental tissue from normotensive, pre-eclamptic and growth retarded pregnancies. Br J Obstet Gynaecol 1995; 102: 711-4.
17. Cockell AP, Poston L. Flow-mediated vasodilation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997; 30: 247-51.
18. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997; 272: R441-63.
19. Nakatsuka M, Takata M, Tada K et al. Long-term transdermal NO donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002; 21: 831-6.
20. De Graaf JC, Bang JD, Moncada S, Palmer RM, de Groot PG, Sixma J. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 1992; 85: 2284-90.
21. Provost P, Lam JYT, Lacoste L, Merhi Y, Waters D. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb 1994; 14: 331-5.
22. Soma H, Yoshida K, Mudaida T, Tabuchi Y. Morphologic changes in the hypertensive placenta. Contrib Gynecol Obstet 1982; 9: 58-75.
23. Perry KJ, Martin JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol, 1992; 35: 338-50.
24. Ali M, Buhimschi I, Chwalisz K, Garfield RE. Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 1997; 3: 995-1003.